Regulation of Tumor Necrosis Factor Alpha Transcription in Macrophages: Involvement of Four κΒ-Like Motifs and of Constitutive and Inducible Forms of NF-κB

Literature Cited

• Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κΒ transcription factor. Cell 53:211–217.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1988. IkB: a specific inhibitor of the NF-κΒ transcription factor. Science 242:540–546.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1989. A 65-kD subunit of active NF-κΒ is required for inhibition of NF-κΒ by I κB. Genes Dev. 3:1689–1698.
   PubMed Web of Science ®Google Scholar
• Baldwin, A. S., and P. A. Sharp. 1988. Two transcription factors, NF-κΒ and H2TF1, interact with a single regulatory sequence in class 1 major histocompatibility complex promoter. Proc. Natl. Acad. Sci. USA 85:723–727.
   PubMedGoogle Scholar
• Beutler, B., and A. Cerami. 1988. The history, properties and biological effects of cachectin. Biochemistry 27:7575–7582.
   PubMed Web of Science ®Google Scholar
• Beutler, B., N. Krochnin, I. W. Milsark, C. Luedke, and A. Cerami. 1986. Control of cachectin (tumor necrosis factor) synthesis: mechanisms for endotoxin resistance. Science 232:977–980.
   PubMed Web of Science ®Google Scholar
• Blanar, M. A., L. C. Burkly, and R. A. Flaveil. 1989. NF-κB binds within a region required for B-cell-specific expression of the major histocompatibility complex class II gene Ed. Mol. Cell. Biol. 9:844–846.
   PubMedGoogle Scholar
• Bohnlein, E., J. W. Lowenthai, M. Siekevitz, D. W. Ballard, B. R. Franza, and W. C. Greene. 1988. The same inducible nuclear proteins regulates mitogen activation of both the inter- leukin-2 receptor alpha gene and type I HIV. Cell 53:827–836.
   PubMedGoogle Scholar
• Collart, M. A., D. Belin, C. Briottet, B. Thorens, J.-D. Vassalli, and P. Vassalli. 1989. Receptor-mediated phagocytosis by macrophages induces a calcium-dependant transient increase in c-fos transcription. Oncogene 4:237–241.
   PubMedGoogle Scholar
• Collart, M. A., D. Belin, J.-D. Vassalli, S. de Kossodo, and P. Vassalli. 1986. y-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1 and urokinase genes, which are controlled by short lived repressors. J. Exp. Med. 164:2113–2118.
   PubMed Web of Science ®Google Scholar
• Collart, M. A., D. Belin, J.-D. Vassalli, and P. Vassalli. 1987. Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription. J. Immunol. 139:949–955.
   PubMed Web of Science ®Google Scholar
• Dorn, A., J. Bollekens, A. Staub, C. Benoist, and D. Mathis. 1987. A multiplicity of CCAAT Box binding proteins. Cell 50:863–872.
   PubMed Web of Science ®Google Scholar
• Goldfeld, A. E., and T. Maniatis. 1989. Coordinate viral induction of tumor necrosis factor a and interferon β in human B cells and monocytes. Proc. Natl. Acad. Sci. USA 86:1490–1494.
   PubMedGoogle Scholar
• Gorski, K., M. Carneiro, and U. Schibler. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767–776.
   PubMed Web of Science ®Google Scholar
• Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. I. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-κΒ. Nature (London) 339:70–73.
   PubMed Web of Science ®Google Scholar
• Hoyos, B., D. W. Ballard, E. Bohnlein, M. Siekevitz, and W. C. Greene. 1989. Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science 244:457–460.
   PubMed Web of Science ®Google Scholar
• Israel, A., A. Kimura, M. Kieran, O. Yano, J. Kanellopoulous, O. LeBail, and P. Kourilsky. 1987. A common positive transacting factor binds to enhancer sequences in the promoters of mouse H-2 and β2 microglobulin genes. Proc. Natl. Acad. Sci. USA 84:2653–2657.
   PubMedGoogle Scholar
• Kawakami, K., C. Scheidereit, and R. G. Roeder. 1988. Identification and purification of a human immunoglobulin-enhancer binding protein (NF-κΒ) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro. Proc. Natl. Acad. Sci. USA 85:470–484.
   Google Scholar
• Lenardo, M. J., C.-M. Fan, T. Maniatis, and D. Baltimore. 1989. The involvement of NF-κΒ in β-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57:287–294.
   PubMed Web of Science ®Google Scholar
• Lenardo, M. J., A. Kuang, A. Gifford, and D. Baltimore. 1988. NF-κΒ protein purification from bovine spleen: nucleotide stimulation and binding site specificity. Proc. Natl. Acad. Sci. USA 85:8825–8829.
   PubMedGoogle Scholar
• Lenardo, M. J., J. W. Pierce, and D. Baltimore. 1987. Proteinbinding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 236:1573–1577.
   PubMed Web of Science ®Google Scholar
• Leung, K., and G. J. Nabel. 1988. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature (London) 333:776–778.
   PubMed Web of Science ®Google Scholar
• Lin, H.-S., and C. C. Stewart. 1974. Peritoneal exudate cells. 1. Growth requirement of cells capable of forming colonies in soft agar. J. Cell. Physiol. 83:369–378.
   PubMedGoogle Scholar
• Lowenthal, J. W., D. W. Ballard, E. Bohnlein, and W. C. Greene. 1989. Tumor necrosis factor a induces proteins that bind specifically to κΒ-like enhancer elements and regulate interleukin 2 receptor α-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. USA 86:2332–2335.
   Google Scholar
• Maxam, A. M., and W. Gilbert. 1980. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499–560.
   PubMedGoogle Scholar
• Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711–713.
   PubMed Web of Science ®Google Scholar
• Nedwin, G. E., L.-P. Svedersky, T. S. Bringman, M. A. Palladino, and D. V. Goeddel. 1985. Effect of interleukin 2, interferon 7 and mitogens on the production of tumor necrosis factors α and β. J. Immunol. 135:2492–2497.
   PubMed Web of Science ®Google Scholar
• Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86:2336–2340.
   PubMed Web of Science ®Google Scholar
• Pierce, J. W., M. Lenardo, and D. Baltimore. 1988. Oligonucleotide that binds nuclear factor NF-κΒ acts as a lymphoidspecific and inducible enhancer element. Proc. Natl. Acad. Sci. USA 85:1482–1486.
   PubMed Web of Science ®Google Scholar
• Ruben, S., H. Poteat, T.-H. Tan, K. Kawakami, R. Roeder, W. Haseltine, and C. A. Rosen. 1988. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-1 tax gene product. Science 241:89–92.
   PubMed Web of Science ®Google Scholar
• Semon, D., E. Kawashima, C. V. Jongeneel, A. N. Shakov, and S. A. Nedospasov. 1987. Nucleotide sequence of the murine TNF locus, including the TNF-α (tumor necrosis factor) and TNF-β (lymphotoxin) genes. Nucleic Acids Res. 15:9083–9084.
   PubMed Web of Science ®Google Scholar
• Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705–716.
   PubMed Web of Science ®Google Scholar
• Sen, R., and D. Baltimore. 1986. Inducibility of κ immunoglobulin enhancer binding protein NF-κΒ by a posttranslational mechanism. Cell 47:921–928.
   PubMed Web of Science ®Google Scholar
• Shakhov, A. N., M. Collart, P. Vassalli, S. A. Nedospasov, and C. V. Jongeneel. 1990. J. Exp. Med. 171:35–47.
   PubMed Web of Science ®Google Scholar
• Shannon, M. F., J. R. Gamble, and M. A. Vadas. 1988. Nuclear proteins interacting with the promoter region of the human granulocyte/macrophage colony-stimulating factor gene. Proc. Natl. Acad. Sci. USA 85:674–678.
   PubMed Web of Science ®Google Scholar
• Sherry, B., and A. Cerami. 1988. The history, properties and biological effects of cachectin. Biochemistry 27:7575–7582.
   PubMedGoogle Scholar
• Shirakawa, F., M. Chedid, J. Suttles, B. A. Pollok, and S. B. Mizel. 1989. Interleukin 1 and cyclic AMP induce κ immunoglobulin light-chain expression via activation of an NF-κB-like DNA-binding protein. Mol. Cell. Biol. 9:959–964.
   PubMed Web of Science ®Google Scholar
• Shirakawa, F., and S. B. Mizel. 1989. In vitro activation and nuclear translocation of NF-κΒ catalyzed by cyclic AMPdependant protein kinase and protein kinase C. Mol. Cell. Biol. 9:2424–2430.
   PubMed Web of Science ®Google Scholar
• Von Ewijk, W., Y. Ron, J. Monaco, J. Kappler, P. Marrack, M. Le Meur, P. Gerlinger, B. Durand, C. Benoist, and D. Mathis. 1988. Compartmentalization of MHC class II expression in transgenic mice. Cell 53:357–365.
   PubMed Web of Science ®Google Scholar
• Visvanathan, K. V., and S. Goodbourn. 1989. Double-stranded RNA activates binding of NF-κΒ to an inducible element in the human β-interferon promoter. EMBO J. 8:1129–1138.
   PubMed Web of Science ®Google Scholar